Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles-Reference-Cited by-同舟云学术

Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles

Published:2020-10-20 Issue: Volume:11 Page:
ISSN:1664-8021
Container-title:Frontiers in Genetics
language:
Short-container-title:Front. Genet.

Author:

Mishra Nitish Kumar,Niu Meng,Southekal Siddesh,Bajpai Prachi,Elkholy Amr,Manne Upender,Guda Chittibabu

Publisher

Frontiers Media SA

Subject

Genetics(clinical),Genetics,Molecular Medicine

Reference98 articles.

1. Dysregulation of Mir-196b in head and neck cancers leads to pleiotropic effects in the tumor cells and surrounding stromal fibroblasts.;Alvarez-Teijeiro;Sci. Rep.,2017

2. ShortStack: comprehensive annotation and quantification of small RNA genes.;Axtell;RNA,2013

3. Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function.;Beltran;Oncogene,2014

4. Controlling the false discovery rate: a practical and powerful approach to multiple.;Benjamini;J. R. Stat. Soc. Ser. B,1995

5. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes.;Braconi;Hepatology,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value and immunological role of MMRN1: a rising star in cancer;Nucleosides, Nucleotides & Nucleic Acids;2024-05-07

2. Integration analysis of miRNA–mRNA expression exploring their potential roles in intrahepatic cholangiocarcinoma;Scientific Reports;2023-05-24

3. DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway;Journal of Orthopaedic Surgery and Research;2023-02-27

4. Low Expression of BRCA1 as a Potential Relapse Predictor in B-Cell Acute Lymphoblastic Leukemia;Journal of Pediatric Hematology/Oncology;2022-11-21

5. Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway;Frontiers in Oncology;2022-08-12